FDA Approved: WINREVAIR — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for WINREVAIR (sotatercept-CSRK) from Merck Sharp & Dohme LLC, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• WINREVAIR (SOTATERCEPT-CSRK)

Snippet

SUPPL AP for WINREVAIR (SOTATERCEPT-CSRK)